ロード中...
Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
Eluxadoline is a novel drug approved for the management of diarrhea predominant irritable bowel syndrome (IBS-D). It has unique pharmacology and works on three different opioid receptors. Several Phase II and III clinical trials have demonstrated eluxadoline’s efficacy in reducing symptoms related t...
保存先:
| 出版年: | Drug Des Devel Ther |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5628681/ https://ncbi.nlm.nih.gov/pubmed/29033544 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S127405 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|